Why Legend Biotech Corporation (LEGN) stock fell 8.6% intraday on Thursday, November 12, 2026
Legend Biotech Corporation (LEGN) traded at $17.87 as of 9:51 AM ET, down 8.55% on Thursday, November 12, 2026, on volume of 352,838 shares (0.2× its 3-month average); market value about $3.50B, according to Nexqual market data (nexqual.com/moves/2026-11-12/LEGN).
LEGN was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.
What happened: primary sources
Events Nexqual found for LEGN on Thursday, November 12, 2026 or the trading day before (November 11, 2026), each linked to its primary source:
- Nov 11, 2026: Oppenheimer: Target lowered, Perform, price target $40 → $25
- Nov 11, 2026: Morgan Stanley: Target lowered, Overweight, price target $49 → $43
- Nov 11, 2026: Barclays: Target lowered, Overweight, price target $68 → $61
- Nov 11, 2026: RBC Capital: Target lowered, Outperform, price target $56 → $50
- Nov 12, 2026: One of 8 Biotechnology stocks among the day's biggest losers (TWST, MANE, PRME, CAPR, ERAS, LEGN, EDIT, SANA), with no comparable group among the biggest gainers
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on LEGN
LEGN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 12, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:48 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:48 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt